Foreign Scientists Pioneer in Japan's Labs

TOKYO—Physicist Ron Scott returned to the United States in 1980 after working in Japan on a one-year grant from the U.S. National Science Foundation. But two years after going back to work for McDonnell-Douglas, he said with his easy Texas drawl, “I felt I hadn’t seen it all. So I returned to Sendai for six months to write a paper.” Six years later Scott is still in Japan, working in the northeastern city of Sendai as a research physicist for the Inaba Biophoton Proj

Written byAlan Engel
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

TOKYO—Physicist Ron Scott returned to the United States in 1980 after working in Japan on a one-year grant from the U.S. National Science Foundation. But two years after going back to work for McDonnell-Douglas, he said with his easy Texas drawl, “I felt I hadn’t seen it all. So I returned to Sendai for six months to write a paper.”

Six years later Scott is still in Japan, working in the northeastern city of Sendai as a research physicist for the Inaba Biophoton Project of the Research Development Corporation of Japan (JRDC). He is one of a small but growing number of foreign scientists who have embraced the chance to work in a Japanese lab. “The idea that Japan is closed to foreign scientists is a myth,” said Scott. “Japan is easily pene- trable—if you are serious.”

Two U.S. universities are developing programs to prepare scientists for work in Japan. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies